The Asia Pacific cell line development market is expected to reach US$ 2,828.53 million in 2027 from US$ 993.09 million in 2019. The market is estimated to grow with a CAGR of 14.1% from 2020-2027.
Cell Line Development is the procedure by which cells are developed under controlled conditions, for the most part outside their common habitat. The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Cell line development have variety of application in healthcare and life science industry such as drug screening, drug development, production of bio production. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment. The scope of the cell line development market includes type, product, application, and region.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC CELL LINE DEVELOPMENT MARKET SEGMENTATION
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
By Type
- Primary Cell Line
- Hybridomas
- Continuous Cell Lines
- Recombinant Cell Line
By Product
- Equipment
- Media & Reagent
By Application
- Drug Discovery
- Bioproduction
- Tissue Engineering
By Country
Asia Pacific
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Company Profiles
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- SELEXIS
- General Electric
- Lonza
- WuXi AppTec
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Product, Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
TABLE OF CONTENTS
1.Introduction
1.1Scope of the Study
1.2The Insight Partners Research Report Guidance
1.3Market Segmentation
1.3.1Cell line development Market – By Type
1.3.2Cell line development Market – By Product
1.3.3Cell line development Market – By Application
1.3.4Asia PacificCell line development Market – By Country
2.Asia Pacific Cell Line Development Market – Key Takeaways
3.Research Methodology
3.1Coverage
3.2Secondary Research
3.3Primary Research
4.Asia PacificCell Line Development Market – Market Landscape
4.1Overview
4.2PEST Analysis
4.2.1Cell Line Development Market- Asia Pacific PEST Analysis
4.3Expert Opinion
5.Asia PacificCell Line Development Market - Key Market Dynamics
5.1Market Drivers
5.1.1High Growth in Investments from the Government in Development of Cell Line
5.1.2Rising Development of the Biotechnology Sector
5.2Market Restraints
5.2.1Multiple Challenges in Cell Line Development
5.3Market Opportunity
5.3.1Increasing Stem Cell Research Regarding Cell Line Development Market
5.4Future Trend
5.4.1GrowingCompany Participation in the Cell Line Development Market
5.5Impact Analysis
6.Cell Line Development Market – Asia Pacific Analysis
6.1Asia PacificCell Line Development Market Revenue Forecasts and Analysis
7.Asia PacificCell Line Development Market Analysis and Forecasts To 2027 – ByType
7.1Overview
7.2Cell Line Development Market, by Type, 2019& 2027 (% Share)
7.3Primary Cell Line
7.3.1Overview
7.3.2Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
7.4Hybridomas
7.4.1Overview
7.4.2Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
7.5Continuous Cell Lines
7.5.1Overview
7.5.2Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
7.6Recombinant Cell Line
7.6.1Overview
7.6.2Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
8.Asia Pacific Cell Line Development Market Analysis and Forecasts To 2027 – ByProduct
8.1Overview
8.2Cell Line Development Market, by Product, 2019& 2027 (% Share)
8.3Equipment
8.3.1Overview
8.3.2Equipment Market Revenue and Forecast to 2027 (US$ Mn)
8.4Media and Reagent
8.4.1Overview
8.4.2Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
9.Asia PacificCell Line Development Market Analysis – ByApplication
9.1Overview
9.2Cell Line Development Market Share by Application 2019& 2027 (%)
9.3Drug Discovery
9.3.1Overview
9.3.2Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
9.4Bioproduction
9.4.1Overview
9.4.2Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
9.5Tissue Engineering
9.5.1Overview
9.5.2Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
10.Cell Line Development Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027
10.1.1Overview
10.1.2Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.3Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.4Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.5Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.6Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.1.7China
10.1.7.1China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.7.3China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.7.4China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.8Japan
10.1.8.1Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.8.3Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.8.4Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.9India
10.1.9.1India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.9.3India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.9.4India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.10South Korea
10.1.10.1South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.10.2South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.10.3South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.10.4South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.11Australia
10.1.11.1Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.11.2Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.11.3Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.11.4Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11.Impact of COVID-19 Pandemic on Asia PacificCell Line Development Market
11.1Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.Company Profiles
12.1Merck KGaA
12.1.1Key Facts
12.1.2Business Description
12.1.3Financial Overview
12.1.4Product Portfolio
12.1.5SWOT Analysis
12.1.6Key Developments
12.2Thermo Fisher Scientific, Inc.
12.2.1Key Facts
12.2.2Business Description
12.2.3Financial Information
12.2.4Product /Services Portfolio
12.2.5SWOT Analysis
12.2.6Key Developments
12.3SELEXIS
12.3.1Key Facts
12.3.2Business Description
12.3.3Financial Overview
12.3.4Product/Service Portfolio
12.3.5SWOT Analysis
12.3.6Key Developments
12.4WuXiAppTec
12.4.1Key Facts
12.4.2Business Description
12.4.3Financial Overview
12.4.4Service Portfolio
12.4.5SWOT Analysis
12.4.6Key Developments
12.5General Electric
12.5.1Key Facts
12.5.2Business Description
12.5.3Financial Overview
12.5.4Product Portfolio
12.5.5SWOT Analysis
12.5.6Key Developments
12.6Lonza
12.6.1Key Facts
12.6.2Business Description
12.6.3Financial Information
12.6.4Product Portfolio
12.6.5SWOT Analysis
12.6.6Key Developments
12.7Corning Incorporated
12.7.1Key Facts
12.7.2Business Description
12.7.3Financial Overview
12.7.4Product Portfolio
12.7.5SWOT Analysis
12.7.6Key Developments
13.Appendix
13.1About the Insight Partners
13.2Glossary of terms
LIST OF TABLES
Table 1.Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2.Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 3.Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 4.China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 5.China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 6.China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 7.Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 8.Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 9.Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 10.India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 11.India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 12.India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 13.South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 14.South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 15.South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 16.Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 17.Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 18.Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 19.Glossary of Terms, Cell Line Development Market
LIST OF FIGURES
Figure 1.Cell Line DevelopmentMarket Segmentation
Figure 2.Asia PacificCell Line Development Market Overview
Figure 3.Media and ReagentSegment Held Largest Share of Product in Cell Line DevelopmentMarket
Figure 4.India is Expected to Show Remarkable Growth During the Forecast Period
Figure 5.Cell Line Development Market - Asia Pacific PEST Analysis
Figure 6.Cell Line Development Market Impact Analysis of Driver and Restraints
Figure 7.Asia PacificCell Line Development Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 8.Cell Line Development Market, Type, 2019& 2027 (% Share)
Figure 9.Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 10.Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
Figure 11.Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
Figure 12.Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13.Cell Line Development Market, By Product, 2019& 2027 (% Share)
Figure 14.Equipment Market Revenue and Forecast to 2027 (US$ Mn)
Figure 15.Media and ReagentMarket Revenue and Forecast to 2027 (US$ Mn)
Figure 16.Cell Line Development Market Share by Application 2019& 2027 (%)
Figure 17.Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
Figure 18.Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
Figure 19.Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20.Asia Pacific Cell Line Development Market Revenue Overview, By Country (2019) (US$ Mn)
Figure 21.Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 22.Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
Figure 23.China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 24.Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 25.India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 26.South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 27.Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 28.Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- SELEXIS
- WuXi AppTec
- General Electric
- Lonza
- Corning Incorporated
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Cell Line Development Market
Mar 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Mar 2020